摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

glutarodihydroxamic acid | 7068-55-5

中文名称
——
中文别名
——
英文名称
glutarodihydroxamic acid
英文别名
Glutarohydroxamic acid;Glutarodihydroxamsaeure;N,N'-dihydroxypentanediamide
glutarodihydroxamic acid化学式
CAS
7068-55-5
化学式
C5H10N2O4
mdl
MFCD25966438
分子量
162.145
InChiKey
VGLJEIRGKRANJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.9
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    98.7
  • 氢给体数:
    4
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    [Zn2(μ-CF3COO)2(CF3COO)2(μ-H2O)(N,N,N',N'-tetramethylethylenediamine)2] 、 glutarodihydroxamic acid甲醇 为溶剂, 以47%的产率得到[Zn4(CF3COO)3(N,N,N',N'-tetramethylethylenediamine)4(glutarodihydroxamate)]
    参考文献:
    名称:
    二,三和四核异羟肟酸锌络合物作为异羟肟酸抑制锌水解酶的结构模型。
    摘要:
    尝试生产结构模型配合物[M2(mu-O2CR)2(O2CR)2(mu-H2O)(tmen)2]的Zn类似物(M = Ni,Co,Mn; R = CH(3),C( CH3)3,CF3)通过一系列羧酸锌与N,N,N',N'-四甲基乙二胺(tmen)的反应生成单核络合物[Zn(OAc)(2)(tmen)](1 )和[Zn(crot)2(tmen)]。对于R = CH3和(CH)2CH3,分别为(0.5)H2O(2)和双核络合物[Zn(2)(mu-piv)(2)( piv)(2)(mu-H2O)(tmen)2](3)和[Zn2(mu-OAc(F))2(OAc(F))2(mu-H2O)(tmen)2](4)对于R分别为C(CH 3)3和CF 3。与类似的咪唑系列相反,即[M2(mu-O2CR)2(O2CR)2(mu-H2O)(Im)4](M = Ni,Co,Mn; R = CH3,C(CH3)3 ,
    DOI:
    10.1021/ic050849m
  • 作为产物:
    描述:
    戊二酸二乙酯羟胺sodium methylate 作用下, 以 甲醇 为溶剂, 生成 glutarodihydroxamic acid
    参考文献:
    名称:
    Hydroxamic Acids As a Novel Family of Serine Racemase Inhibitors: Mechanistic Analysis Reveals Different Modes of Interaction with the Pyridoxal-5′-phosphate Cofactor
    摘要:
    Mammalian serine racemase (SR) is a pyridoxal-5-phosphate (PLP) dependent enzyme responsible for the biosynthesis of the neurotransmitter D-Scrine, which activates N-methyl-D-aspartate (NMDA) receptors in the CNS. Aberrant regulation of NMDA receptor signaling has been implicated in a variety of neuropathologies, and inhibitors of SR would therefore be a worthwhile too] for further investigation or treatment of such conditions. Here, we identify a series of small aliphatic hydroxamic acids (HAS) that act as potent SR inhibitors. However, specificity studies showed that some of these HAS can act as nonspecific inhibitors of PLP-dependent enzymes. We employed NMR, MS, and UV/vis spectroscopic techniques to reveal that the nonspecific effect is likely due to irreversible interaction of the HA moiety with PLP to form aldoxime species. We also characterize L-aspartic acid beta-hydroxamate as a competitive and selective SR inhibitor that could be used as a scaffold for further inhibitor development.
    DOI:
    10.1021/jm900775q
点击查看最新优质反应信息

文献信息

  • Novel elimination of hydroxylamine and formation of a nickel tetramer on reactions of glutarodihydroxamic acid with model dinickel hydrolases‡
    作者:David A. Brown、Laurence P. Cuffe、Noel J. Fitzpatrick、William K. Glass、Kara Herlihy、Hassan Nimir、Oliver Deeg、William Errington、Terence J. Kemp
    DOI:10.1039/a806911e
    日期:——
    Reactions of glutarodihydroxamic acid with the hydrolase enzyme urease models, [Ni2(µ-H2O)(OAc)4(tmen)2] and [Ni2(OAc)3(urea)(tmen)2][OTf], lead to novel hydroxylamine elimination and formation of [Ni2(OAc)2µ-O(N)(OC)2(CH2)3}(tmen)2][OTf] and the tetramer [Ni4(OAc)2(gluA2)2(tmen)4][OTf]2, respectively, both of which are structurally characterised by X-ray crystallography.
    戊二羟肟酸与水解酶脲酶模型 [Ni2(µ-H2O)(OAc)4(tmen)2] 和 [Ni2(OAc)3(urea)(tmen)2][OTf] 的反应,产生新型羟胺消除和形成 [Ni2(OAc)2µ-O(N)(OC)2(CH2)3}(tmen)2][OTf] 和分别是四聚体[Ni4(OAc)2(gluA2)2(tmen)4][OTf]2,两者均通过X射线晶体学进行了结构表征。
  • Structure determination of dihydroxamic acids and their trimethylsilyl derivatives by NMR spectroscopy
    作者:Jan Schraml、Magdalena Kv�?alov�、Vratislav Blechta、Ludmila Soukupov�、Otto Exner、Hans-Michael Boldhaus、Frank Erdt、Claus Bliefert
    DOI:10.1002/1097-458x(200009)38:9<795::aid-mrc732>3.0.co;2-a
    日期:2000.9
    and hydroximic structures, the most reliable parameter is the 15N chemical shift, which differs in the two classes of compounds by about 120 ppm. To differentiate E and Z hydroxamic conformers 13C chemical shifts of C O groups are preferable to 15N chemical shifts but for distinguishing E and Z isomers of the hydroximic structure both 15N and 13C NMR of the C N group are useful. 17O NMR data are of
    制备同源系列的二异羟肟酸 [HONHCO(CH2)nCONHOH,n = 0、1、2、3、4 和 6] 并进行三甲基甲硅烷基化 [1(n) 和 2(n)]。1(n) 的溶液 NMR 光谱 (1H, 13C, 15N) 表明异羟肟端基假定构象异构体的 Z-Z 和 Z-E 组合。一个例外是草酰二异羟肟酸,它假定只有一种组合。13C 交叉极化魔角旋转再现了该化合物的溶液化学位移,并表明了之前通过 X 射线衍射确定的 Z-Z 组合。三甲基甲硅烷基化生成两端均具有羟基结构的化合物,两个基团都被二甲硅烷基化。Z-Z、Z-E 和 E-E 异构体组合在光谱中可见,并且可以确定它们的比例。同样,草酰二羟肟酸衍生物是一个例外:只发现了一种硅烷化产物,无法确定其几何形状。选择性去耦实验(15N1H} 和 13C1H})是用于识别 E 和 Z 构象异构体的 15N 富集的廉价替代方法。为了区分异羟肟和异羟肟结构,最可靠的参数是
  • Conformational behaviour of hydroxamic acids: ab initio and structural studies
    作者:David A. Brown、Raymond A. Coogan、Noel J. Fitzpatrick、William K. Glass、Dau E. Abukshima、Loreto Shiels、Markku Ahlgrén、Kimmo Smolander、Tuula T. Pakkanen、Tapani A. Pakkanen、Mikael Peräkylä
    DOI:10.1039/p29960002673
    日期:——
    The conformational behaviour of a series of monohydroxamic acids, p-RC(6)H(4)CONR'OH (R = Me, R' = H, Me; R = MeO, R' = H, Me; R = NO2, R' = H), and a series of dihydroxamic acids, (CH2)(n)(CONR'OH)(2) (n = 3-8, 10, R' = H and n = 7, R' = Me), in methanol, DMSO and chloroform and in the solid state has been examined using IR and NMR spectroscopy, X-Ray crystal structure determinations of p-MeC(6)H(4)CONMeOH and the monohydrate of glutarodihydroxamic acid (n = 3) together with ab initio molecular orbital calculations for several hydrated and unhydrated hydroxamic acids have been performed. Hydrogen bonding effects are shown to be important in both the solid state and solution, The cis(Z) conformation of the hydroxamate group(s) (CONHOH) is preferentially stabilized by hydrogen bonding with water molecules.
  • Hydroxylamine derivatives as potential antimalarial agents. 1. Hydroxamic acids
    作者:John B. Hynes
    DOI:10.1021/jm00300a056
    日期:1970.11
  • Brown, D. A.; Geraty, R. A.; Glennon, J. D., Synthetic Communications, 1985, vol. 15, # 13, p. 1159 - 1164
    作者:Brown, D. A.、Geraty, R. A.、Glennon, J. D.、Choileain, N. Ni
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物